We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current APLI market cap is 1.82M. The company's latest EPS is CAD -0.0216 and P/E is -0.46.
| Year End March 30 2025 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 660k | 1.65M | 383k | 6.69M | 11.39M |
| Operating Income | -14.38M | -23.61M | -7.76M | -2.15M | 1.25M |
| Net Income | -14.33M | -25.12M | -9.24M | -3.78M | -2.62M |
| Year End March 30 2025 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 18.32M | 8.28M | 3.13M | 1.49M | 3.03M |
| Total Liabilities | 5.56M | 11.55M | 10.53M | 12.42M | 16.43M |
| Total Equity | 12.75M | -3.27M | -7.4M | -10.93M | -13.4M |
| Year End March 30 2025 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | -11.45M | -19.08M | -10.1M | -2.46M | 868k |
| Investing | -4.99M | 5.06M | -3k | -29k | -2k |
| Financing | 17.02M | 9.56M | 5.91M | 122k | 194k |
| Market Cap | 1.82M |
| Price to Earnings Ratio | -0.46 |
| Price to Sales Ratio | 0.11 |
| Price to Cash Ratio | 0.99 |
| Price to Book Ratio | -0.09 |
| Dividend Yield | - |
| Shares Outstanding | 121.27M |
| Average Volume (1 week) | 10.16k |
| Average Volume (1 Month) | 59k |
| 52 Week Change | -57.14% |
| 52 Week High | 0.045 |
| 52 Week Low | 0.01 |
| Spread (Intraday) | 0.01 (25%) |
| Company Name | Appili Therapeutics Inc |
| Address |
21-1344 summer street halifax, nova scotia B3H 0A8 |
| Website | https://www.appilitherapeutics.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
